The influence of beta-arrestin2 on cannabinoid CB₁ receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain

References

• Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561–4
   PubMed Web of Science ®Google Scholar
• Kaminski NE, Abood ME, Kessler FK, et al. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 1992;42:736–42
   PubMed Web of Science ®Google Scholar
• Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61–5
   PubMed Web of Science ®Google Scholar
• Lynn AB, Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Therapeut 1994;268:1612–23
   PubMed Web of Science ®Google Scholar
• Bouaboula M, Rinaldi M, Carayon P, et al. Cannabinoid-receptor expression in human leukocytes. Eur J Biochem/FEBS 1993;214:173–80
   PubMedGoogle Scholar
• Breivogel CS, Sim-Selley LJ. Basic neuroanatomy and neuropharmacology of cannabinoids. Int Rev Psychiatry 2009;21:113–21
   PubMed Web of Science ®Google Scholar
• Prather PL, Martin NA, Breivogel CS, Childers SR. Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein α-subunits with different potencies. Mol Pharmacol 2000;57:1000–10
   PubMed Web of Science ®Google Scholar
• Howlett AC. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci 1984;35:1803–10
   PubMed Web of Science ®Google Scholar
• Glass M, Felder CC. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997;17:5327–33
   PubMed Web of Science ®Google Scholar
• Maneuf YP, Brotchie JM. Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br J Pharmacol 1997;120:1397–8
   PubMed Web of Science ®Google Scholar
• Mackie K, Lai Y, Westenbroek R, Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995;15:6552–61
   PubMed Web of Science ®Google Scholar
• Bouaboula M, Poinot-Chazel C, Bourrié B, et al. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 1995;312:637–41
   PubMed Web of Science ®Google Scholar
• McLemore GL, Cooper RZ, Richardson KA, et al. Cannabinoid receptor expression in peripheral arterial chemoreceptors during postnatal development. J Appl Physiol 2004;97:1486–95
   Google Scholar
• Jeffery DR, Charlton RR, Venter JC. Reconstitution of turkey erythrocyte beta-adrenergic receptors into human erythrocyte acceptor membranes. Demonstration of guanine nucleotide regulation of agonist affinity. J Biol Chem 1980;255:5015–18
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Childers SR. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J Pharmacol Exp Therapeut 2000;295:328–36
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Inglese J, Koch WJ, et al. G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins. Cold Spring Harbor Symposia Quant Biol 1992;57:127–33. Epub 1 January 1992
   PubMedGoogle Scholar
• Premont RT, Gainetdinov RR. Physiological roles of G protein-coupled receptor kinases and arrestins. Ann Rev Physiol 2007;69:511–34
   PubMed Web of Science ®Google Scholar
• Zidar DA, Violin JD, Whalen EJ, Lefkowitz RJ. Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc Natl Acad Sci USA 2009;106:9649--54
   PubMed Web of Science ®Google Scholar
• Reiter E, Lefkowitz RJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends in endocrinology and metabolism: TEM 2006;17:159–65. Epub 6 April 2006
   PubMed Web of Science ®Google Scholar
• Bohn LM, Dykstra LA, Lefkowitz RJ, et al. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 2004;66:106–12
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Lambert JM, Gerfin S, et al. Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 −/− mice. Behav Pharmacol 2008;19:298–307
   PubMed Web of Science ®Google Scholar
• Gurevich EV, Benovic JL, Gurevich VV. Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 2002;109:421–36
   PubMed Web of Science ®Google Scholar
• Gurevich EV, Benovic JL, Gurevich VV. Arrestin2 expression selectively increases during neural differentiation. J Neurochem 2004;91:1404–16
   Google Scholar
• Jin W, Brown S, Roche JP, et al. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J Neurosci 1999;19:3773–80
   Google Scholar
• Kouznetsova M, Kelley B, Shen M, Thayer SA. Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. Mol Pharmacol 2002;61:477–85
   Google Scholar
• Daigle TL, Kwok ML, Mackie K. Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J Neurochem 2008;106:70–82
   PubMed Web of Science ®Google Scholar
• Gainetdinov RR, Premont RT, Caron MG, Lefkowitz RJ. Reply: receptor specificity of G-protein-coupled receptor kinases. Trends Pharmacol Sci 2000;21:366–7
   Google Scholar
• Nguyen PT, Schmid CL, Raehal KM, et al. beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner. Biol Psychiatr 2012;71:714–24. Epub 21 January 2012
   PubMed Web of Science ®Google Scholar
• Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Ann Rev Pharmacol Toxicol 2012;52:179–97. Epub 29 September 2011
   PubMedGoogle Scholar
• Raehal KM, Walker JK, Bohn LM. Morphine side effects in beta-arrestin 2 knockout mice. J Pharmacol Exp Therapeut 2005;314:1195–201
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54
   PubMed Web of Science ®Google Scholar
• Graham J, Rickwood D. Subcellular fractionation: a practical approach. Oxford, UK: Oxford University Press; 1997. 352 p
   Google Scholar
• Moore RJ, Xiao R, Sim-Selley LJ, Childers SR. Agonist-stimulated [35S]GTPgammaS binding in brain modulation by endogenous adenosine. Neuropharmacology 2000;39:282–9
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Griffin G, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 2001;60:155–63
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Selley DE, Childers SR. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 1998;273:16865–73
   PubMed Web of Science ®Google Scholar
• Herkenham M, Lynn AB, Little MD, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990;87:1932–6
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Sim LJ, Childers SR. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Therapeut 1997;282:1632–42
   PubMed Web of Science ®Google Scholar
• Attramadal H, Arriza JL, Aoki C, et al. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 1992;267:17882–90
   PubMed Web of Science ®Google Scholar
• Luttrell LM, Roudabush FL, Choy EW, et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 2001;98:2449–54
   PubMed Web of Science ®Google Scholar
• van der Lee MM, Blomenrohr M, van der Doelen AA, et al. Pharmacological characterization of receptor redistribution and {beta}-arrestin recruitment assays for the cannabinoid receptor 1. J Biomol Screen 2009;14:811--23
   PubMedGoogle Scholar
• Breivogel CS, Lambert JM, Gerfin S, et al. Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 −/− mice. Behav Pharm 2008;19:298–307. Epub 16 July 2008
   PubMed Web of Science ®Google Scholar
• Dalton GD, Howlett AC. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells. Br J Pharmacol 2012;165:2497–511. Epub 27 April 2011
   Google Scholar
• Bohn LM, Lefkowitz RJ, Gainetdinov RR, et al. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 1999;286:2495–8. Epub 5 January 2000
   PubMed Web of Science ®Google Scholar
• Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Therapeut 2011;336:296–302. Epub 30 October 2010
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Childers SR, Deadwyler SA, et al. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 1999;73:2447–59
   PubMed Web of Science ®Google Scholar